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Leptospira interrogans causes leptospirosis, one of the most common zoonotic diseases in the world. This
pathogenic spirochete is able to bind to extracellular matrix, to express virulent factors and to cause host
death. Until now, there is no effective human vaccine for the disease. Shotgun phage display genomic
libraries of L. interrogans were constructed and used for in vivo biopanning in hamsters and screened
for ligands able to bind to LLC-PK1 epithelial cells. In both panning procedures, clones coding for the
putative lipoprotein LIC12976 were identiﬁed and, in order to conﬁrm its adhesin activity, a recombinant
protein was produced in Escherichia coli and showed to interact with A31 ﬁbroblasts, LLC-PK1 and Vero
epithelial cells in vitro. Moreover, rLIC12976 was shown to bind to laminin, indicating an adhesin func-
tion. This protein was also detected in extracts of L. interrogans from different serovars and it was found to
be conserved among pathogenic leptospires. Further, the protein was tested as vaccine candidate and
immunization of hamsters with LIC12976 did not confer protection against a lethal challenge with the
homologous L. interrogans serovar Copenhageni. Nevertheless, LIC12976 seems to act as an adhesin,
and may be important for the host–pathogen interaction, so that its study can contribute to the under-
standing of the virulence mechanisms in pathogenic leptospires.
 2013 Elsevier Inc. Open access under the Elsevier OA license. 1. Introduction
Leptospira is the etiologic agent of leptospirosis, a zoonosis rec-
ognized as an emerging infectious disease that is extremely spread
throughout the world [1,2]. The disease transmission, directly or
indirectly from animals to humans, is through cuts and abrasions
in the skin or via the conjunctiva, and may also occur in intact skin
after prolonged exposure to water contaminated with urine of in-
fected animals [1].
The knowledge on the mechanism of pathogenicity of Leptospira
is very limited [1,3]. Nowadays, the genomes of nine strains of the
genus Leptospira were sequenced: L. interrogans serovar Lai [4], L.
interrogans strain Fiocruz L1–130 serovar Copenhageni [5], JB197
and L550 strains from Leptospira borgpetersenii serovar Hardjo
[6], Leptospira santorosai serovar Shermani [7], VAR010 and
MMD0835 strains from Leptospira licerasiae serovar Varillal [8]gia, Instituto Butantan, CEP
.
ier OA license. and Leptospira biﬂexa serovar Patoc strains Paris and Ames [9].
Comparative genomic studies can provide knowledge about mech-
anisms of pathogenicity and thus help to establish strategies to
control the disease and to identify potential candidates for drugs
or vaccine development [2,5].
Bacteria interacting with eukaryotic hosts express adhesive
molecules on their surfaces that mediate adhesion to a receptor
on the target cell surface or with soluble macromolecules and what
can head the pathogen to a speciﬁc location in the host [10]. Path-
ogenic bacteria utilize numerous mechanisms to cause disease in
humans. The ﬁrst step in host–pathogen interaction and tissue col-
onization is the adherence to the surface of the cell or to extracel-
lular matrix proteins. Once attached, pathogens are able to initiate
speciﬁc biochemical processes that include proliferation, secretion
of toxins, immune evasion responses and cell invasion, culminating
in the appearance of disease symptoms [11].
Jacobsson and Frykberg [12] were pioneers to identify adhesins
using the shotgun phage display. In this technique, the phage li-
brary is constructed from random fragments from genomic DNA.
Shotgun phage display has identiﬁed a number of genes coding
for adhesins involved in host-pathogen interactions [13–15].
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through in vivo and in vitro screening a shotgun phage display li-
brary constructed using genomic DNA from L. interrogans serovar
Copenhageni. In agreement, we showed that the recombinant pro-
tein rLIC12976 is able to bind to mammalian cells, including kid-
ney epithelial cells and laminin.2. Materials and methods
2.1. Microorganisms and culture condition
L. interrogans serovar Copenhageni Fiocruz L1–130 was ob-
tained from ATCC catalog BAA-1198. It was cultivated as described
[16]. Virulence was maintained by iterative passages in Golden
Syrian hamsters.
2.2. Library construction, biopanning and sequence analysis
The libraries construction and the in vivo biopanning were done
as described [17–19]. Brieﬂy, hamsters were anesthetized intraper-
itoneally with 2.5% Avertin [20] and the thoracic cavity was opened
in order to expose the heart. 1  109 phages/mL (200 lL/animal)
from the library were injected directly into the animal heart. After
5 min of phage circulation, the animal was perfused and the
phages were recovered by removing the kidneys. The panning pro-
cedure was repeated for four rounds. This study has the approval of
the Ethics Committee for Animal Use from Instituto Butantan, pro-
tocol number 564/08. The in vitro biopanning was performed
according the BRASIL methodology [21] with modiﬁcations. Brieﬂy,
1  1012 phages/mL (100 lL/tube) were incubated with 1  106 pig
kidney epithelial LLC-PK1 cells. After centrifugation, the phages in
the precipitate were eluted by low pH, neutralized with Tris–HCl
pH 8.0, centrifuged after the addition of 1% BSA-DMEM to remove
cellular debris and the supernatant was again incubated with LLC-
PK1 cells. After panning procedures, clones of each round were
analyzed as described [18].
2.3. Cloning, expression, puriﬁcation of rLIC12976 and antisera
production
Leptospira’s genomic DNAs were extracted using DNAzol Re-
agent (Invitrogen). The gene lic12976 was ampliﬁed by PCR using
speciﬁc primers forward 50 TAGGCTCGAGGAACGTCATTCTCTTC 30
and reverse 50 ACCAAGCTTCTAAAAACGTTCCGAATT 30 containing
Xho I and Hind III restriction sites (bold). The ampliﬁed product
from L. interrogans serovar Copenhageni genomic DNA was cloned
into the pGEM-T easy vector (Promega) and subcloned into the pAE
vector [22], as described [18]. E. coli BL21 Star (DE3) pLysS was
used for protein expression overnight at 20 C and the puriﬁcation
of the recombinant protein was performed as described [23]. The
presence of the recombinant protein was evaluated by 12% SDS–
PAGE, the fractions of interest were dialysed against PBS and the
protein was quantiﬁed by Bradford (Bio-Rad). The antisera against
rLIC12976 and immunoblot assay were performed as described
[23,24], using BSA 2% in PBST during incubation with antiserum.
2.4. Bioinformatic analysis
The PSORT program (http://psort.nibb.ac.jp/) was used to pre-
dict the sub cellular localization of the protein. Public and custom
sequence-speciﬁc search algorithms were used for identiﬁcation of
sequence motifs including signal peptides, lipoprotein cleavages
sites and transmembrane domains (http://www.cbs.dtu.dk/ser-
vices/TMHMM) and (http://www.cbs.dtu.dk/services/SignalP), as
described [25].2.5. Binding of rLIC12976 to mammalian cells and extracellular matrix
components
A31 (mouse BALB/c3T3 clone A31 ﬁbroblast), Vero (african
green monkey kidney epithelial cell – Cercopithecus aethiops) and
LLC-PK1 (pig kidney epithelial cell – Sus scrofa) cells were culti-
vated and ﬁxed as described [18]. The binding procedure was per-
formed according [16] with modiﬁcations. Brieﬂy, Nunc MaxiSorp
microtiter plates were coated with 1.0 lg of plasma ﬁbronectin,
ﬁbrinogen, BSA, laminin, cellular ﬁbronectin and monosialogan-
glioside GM1 (all purchased from Sigma–Aldrich) and were incu-
bated at 4 C overnight and washed three times with PBST (0.1%
Tween). The cells and the ECM proteins were blocked with
200 lL of 1% BSA in PBST and 10% BSA in PBST, respectively. The
incubation were proceed at 37 C for 1 h and then at 4 C for
16 h. After three washes with PBST, 1.0 lg of rLIC12976 protein
was diluted in PBS, incubated for 1 h and 30 min at 37 C and
washed six times with PBST. The detection was performed by incu-
bation with polyclonal antisera anti-LIC12976 1:5000 dilution for
1 h at 37 C followed by three washes with PBST and incubation
with anti-mouse IgG peroxidase conjugate 1:10,000 dilution. After
three washes with PBST, the plate was developed as described [23].
For competition experiments, rLIC12976 was incubated with lam-
inin (0, 0.5, 1.0 and 5.0 lg) for 1 h and 30 min before the incubation
with the cells.
2.6. Immunization of hamsters and leptospiral challenge
All procedures were approved by the Committee for the Use of
Experimental Animals of the Faculdade de Medicina Veterinária e
Zootecnia, Universidade de São Paulo, São Paulo, SP, Brazil. Immu-
nization and challenge were done as described [26].3. Results
3.1. LIC12976 was selected by in vivo and in vitro biopanning and it is
conserved in pathogenic leptospiral genomes
After four rounds of in vivo biopanning through hamster perfu-
sion combined with the recovering of the phages from kidneys in
parallel with in vitro biopanning against kidney epithelial LLC-
PK1 cells, two and one, respectively, phage clones in frame coding
for a partial sequence of LIC12976 were selected. LIC12976 en-
codes a putative lipoprotein with 47.7 kDa of molecular mass cor-
responding to 418 amino acids residues and pI 8.12. This protein
possesses a signal peptide, but functionally motifs besides the lipo-
box, were not identiﬁed (Supplementary Fig. 1). A PCR using prim-
ers designed on L. interrogans serovar Copenhageni strain Fiocruz
L1–130 DNA sequence was used to investigate the presence of this
gene in other Leptospira serovars. Indeed, this gene was ampliﬁed
in all pathogenic serovars assayed of the species L. interrogans,
comprising a fragment of approximately 1.2 kb, but not in the sap-
rophytic L. biﬂexa serovar Patoc (Fig. 1), conﬁrming that lic12976 is
conserved in pathogenic leptospires species. The recombinant
LIC12976 (rLIC12976) with 45.8 kDa corresponding to amino acid
29–418 was expressed and puriﬁed.
3.2. rLIC12976 is expressed in pathogenic Leptospira serovars
The polyclonal antiserum against rLIC12976 was able to specif-
ically recognize the recombinant protein (Fig. 2A) but not other L.
interrogans recombinant proteins. Immunoblot analysis were also
performed on a panel of Leptospira serovar extracts and the antise-
rum against rLIC12976 reacted with a band corresponding to a
molecular mass of LIC12976 in all pathogenic serovar samples
Fig. 1. PCR ampliﬁcation of the gene encoding the LIC12976 in L. interrogans
serovars Copenhageni, Autumnalis, Canicola, Hardjo, Icterohaemorrhagiae, Pomona
and Pyrogenes and L. biﬂexa serovar Patoc. M is the molecular marker 1 kb plus
(Invitrogen).
Fig. 2. (A) Polyclonal serum raised against LIC12976 is speciﬁc against the
homologous recombinant protein. Other recombinant proteins were tested, such
as LigA [37], LipL32 [24], TlyC [27], LIC11399 (Hashimoto V.L., unpublished results),
LIC13435 [28], LIC13418 (Lima S.S., unpublished results). (B) Presence of LIC12976
protein in L. interrogans serovars. Sera frommice immunized with LIC12976 reacted
with the native protein from whole cell extracts of pathogenic L. interrogans
serovars Australis, Bratislava, Canicola, Pyrogenes, Hardjo and Copenhageni but
failed to recognize the L. biﬂexa serovar Patoc. Sera also react with the rLIC12976.
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geni). In accordance to the result that lic12976 presence is con-
served in pathogenic leptospires species, no reaction was
observed with nonpathogenic saprophytic L. biﬂexa serovar Patoc
(Fig. 2B) indicating that LIC12976 is only expressed by pathogenic
leptospires.
3.3. rLIC12976 binds to mammalian cells and laminin in vitro
Since LIC12976 was identiﬁed after panning against kidney
(in vivo) and LLC-PK1 epithelial kidney cells (in vitro), the recombi-
nant protein rLIC12976 was subjected to binding assays to mam-
malian cells, what showed that rLIC12976 was able to adhere to
all tested cells including LLC-PK1 (Fig. 3A). In order to identify pos-
sible cellular targets of LIC12976, plasma and ECM puriﬁed pro-
teins were also assayed. We showed that rLIC12976 was able to
bind to laminin (Fig. 3B). TlyC was used as positive [27] and
LIC13435 as negative control [28], respectively (data not shown).Competition assays were performed to investigate if laminin was
able to inhibit the binding of rLIC12976 to mammalian cells
(A31, LLC-PK1 or Vero). Nevertheless, using different concentra-
tions of laminin (0, 0.5, 1.0 and 5.0 lg), higher binding of the re-
combinant protein to the cells was observed. When we probed
the experiment with anti-laminin antibodies, we observed that
the laminin added to the cultures was able to bind to the cells
(Fig. 3C and D). In the binding assay, rLIC12976 different concen-
trations were tested and showed that the interaction with mam-
malian cells and laminin is rLIC12976 concentration dependent;
when higher concentration is used, more ligation is observed (data
not shown).3.4. rLIC12976 was not protective against a lethal leptospiral challenge
in hamsters
In order to evaluate the potential of LIC12976 as a vaccine anti-
gen against leptospirosis, hamsters were immunized with
rLIC12976 and challenged with virulent L. interrogans serovar
Copenhageni. It was observed that LIC12976 was not a protective
antigen, in contrast to LigAC [29], a L. interrogans immunoglobu-
lin-like protein used as a positive control (Fig. 4). To date, the most
promising vaccine candidate is the C-terminal portion of LigA,
which although not being able to completely eliminate leptospires
from kidneys, confers protection in a hamster model of leptospiro-
sis [26].4. Discussion
L. interrogans shotgun phage display libraries were constructed
in order to characterize new adhesins. Many adhesins have been
identiﬁed in pathogenic bacteria using this technique
[14,18,19,30–32].
In this work, LIC12976 was identiﬁed after in vivo and in vitro
biopanning. It codes for a lipoprotein and our results showed that
it was expressed in all tested L. interrogans pathogenic serovars.
We also observed that rLIC12976 was able to bind to mammalian
cells and speciﬁcally to laminin. Interestingly, addition of laminin,
instead of competing with rLIC12976 for cell binding, enhanced the
interaction of rLIC12976 to the cells, indicating that laminin medi-
ates the binding of rLIC12976 to the cells, what probably led to
higher binding levels of rLIC12976 to the cells.
Lipoproteins are a set of bacterial membrane proteins with
many different functions. These proteins are required for virulence
of many pathogenic bacteria, and potentially play a key role in
host–pathogen interactions ranging from adhesion to the surface
of the host cells with the induction of inﬂammatory processes to
the translocation of virulence factors into the host cell cytoplasm
[33]. In Leptospira, lipoproteins have important structural and
functional roles; they may be enzymes, transporters, adhesins, tox-
ins and other proteins essential for bacterial virulence [34].
The immunogenic proteins, specially the outer membrane sur-
face proteins, may be effective as candidates for a new vaccine.
The identiﬁcation of proteins, which are conserved among patho-
genic leptospires and can crossprotect against various serovars,
has become a major focus of leptospiral research [25]. In the tested
conditions, rLIC12976 did not present protective properties as a
vaccine antigen, despite the fact that this recombinant protein is
immunogenic. The lack of protection may be related to the pres-
ence of many different adhesins in leptospires (see references be-
low). This suggest that there is a probable redundant system for
bacterial adhesion to host, based on the diversity of these proteins,
that is not signiﬁcantly affected when just one adhesin activity is
impaired. Furthermore, future studies combining rLIC12976 with
other protein antigens and also with novel adjuvants could be per-
Fig. 3. Adhesion of the rLIC12976 to cells, extracellular matrix components (ECM) and plasma proteins. (A) 96-well plates were plated with A31, LLC-PK1 and Vero cells. (B)
ELISA plates wells were coated with 1 lg of BSA, GM1, plasma ﬁbronectin, cellular ﬁbronectin, ﬁbrinogen and laminin. One microgram of rLIC12976 protein was added per
well and further revealed with anti-rLIC12976. In control, A31, LLC-PK1 and Vero cells were incubated with the primary and secondary antibodies only. (C) and (D)
Competition assay was performed with different concentrations of laminin and rLIC12976 incubated with A31, LLC-PK1 and Vero cells and revealed with anti-LIC12976 or
anti-laminin, respectively.
Fig. 4. Survival of hamsters immunized with rLIC12976 and challenged with
virulent L. interrogans serovar Copenhageni str. Fiocruz L1–130.
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candidate.
The ability of L. interrogans to cause disease is complex and mul-
tifactorial. Studies have shown that this bacterium is able to enter
into phagocytic and non-phagocytic cells, and interact with cul-
tured ﬁbroblasts, epithelial cells, endothelial cells and microglial
cells, indicating that pathogen surface molecules have a role in
adhesion and invasion of the host tissue [2].So far, several Leptospira adhesins have been identiﬁed due to
the ability to bind to host such as the LipL32 speciﬁcally binds to
ﬁbronectin and type IV collagen [24,35]; Lsa24/LenA and Lsa 21,
the ﬁrst speciﬁcally binds to laminin and the second is capable of
binding to laminin, type IV collagen and ﬁbronectin [16,36]; LigA
e LigB, both with adhesion proprieties to immobilized ECM and
plasma proteins [37] and heparin [18]. LenB, LenC, LenD, LenE e
LenF (all paralogs of LenA) that exhibit afﬁnity for ﬁbronectin
[38]. The adhesin TlyC binds to laminin, collagen IV and plasma
ﬁbronectin [27]. Lsa20 binds to laminin and to plasminogen [39].
Lsa66 and Lsa30 bind to laminin and plasma ﬁbronectin [40,41].
The large amount of adhesins identiﬁed up to now in pathogenic
leptospires is intriguing. It may represent redundant processes to
bind to the host to assure the rate of the infection success.
This is the ﬁrst report about a leptospiral lipoprotein identiﬁed
by panning against epithelial kidney cells and also from hamster’s
kidneys. The identiﬁcation of a same putative protein in both inde-
pendent techniques strongly suggests that this putative lipopro-
tein, LIC12976, could be a new adhesin. Together with the
observation that lic12976 gene is expressed in pathogenic lepto-
spires, our data suggest that this protein may be important for
the host interaction process. Binding to the host cell by adhesin
is one of the most important skills for the onset of the disease.
Thus, research involving the characterization of adhesins may con-
tribute to the knowledge of the ﬁrst molecular steps involved in
host-pathogen interaction. In addition, the search for adhesins
346 S.S. Lima et al. / Biochemical and Biophysical Research Communications 431 (2013) 342–347may contribute to the development of vaccines that would block
the early stages of infection, such as cell adhesion, preventing bac-
terial infection [42–44].
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